Loading…
Loading…
Laboratory Corp Of America Holdings
NYSE · Stock Profile · Market Cap $22.04B
Current Price
$265.84
-1.77%GoodMoat Value
$345.01
29.8% undervaluedPrice sits at 70% of its 52-week range.
Forward estimates use 18.6% FCF growth (CAGR)
Net Debt: 6.0B
3.2B
FY24
3.3B
FY24
13.0B
FY24
3.3B
FY25
3.5B
FY25
3.6B
FY25
14.0B
FY25
205M
FY24
169M
FY24
746M
FY24
213M
FY25
238M
FY25
261M
FY25
877M
FY25
Laboratory Corporation of America Holdings is a clinical laboratory company in the United States. Through a national network of laboratories, the Company offers a range of testing services used by the medical profession in routine testing, patient diagnosis, and in the monitoring and treatment of disease. In addition, it has developed specialty and niche operations based on certain types of specialized testing capabilities and client requirements, such as oncology testing, human immunodeficiency virus (HIV) genotyping and phenotyping, diagnostic genetics and clinical research trials. It processes tests on approximately 470,000 patient specimens daily and provides clinical laboratory testing services in all 50 states, the District of Columbia, Puerto Rico, Belgium, Japan, the United Kingdom, China, Singapore and three provinces in Canada.
Sector
Healthcare
Industry
Diagnostics & Research
Exchange
NYSE
Country
North Carolina, USA
Trading 30% below its estimated fair value of $345.01.
Blended fair value estimate based on DCF, Graham Number, and earnings-based models.
Run a full DCF analysis with customizable assumptions
Open DCF Calculator →Graham Number, PEG-based, and Earnings-based models
View Fair Value →Dividend Yield
1.09%
Laboratory Corporation of America Holdings is a clinical laboratory company in the United States. Through a national network of laboratories, the Company offers a range of testing services used by the medical profession in routine testing, patient diagnosis, and in the monitoring and treatment of disease. In addition, it has developed specialty and niche operations based on certain types of specialized testing capabilities and client requirements, such as oncology testing, human immunodeficiency virus (HIV) genotyping and phenotyping, diagnostic genetics and clinical research trials. It processes tests on approximately 470,000 patient specimens daily and provides clinical laboratory testing services in all 50 states, the District of Columbia, Puerto Rico, Belgium, Japan, the United Kingdom, China, Singapore and three provinces in Canada.
Sector
Healthcare
Industry
Diagnostics & Research
Exchange
NYSE
Country
North Carolina, USA